Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 1:254:117788.
doi: 10.1016/j.lfs.2020.117788. Epub 2020 May 13.

The role of biomarkers in diagnosis of COVID-19 - A systematic review

Muhammed Kermali  1 , Raveena Kaur Khalsa  1 , Kiran Pillai  1 , Zahra Ismail  1 , Amer Harky  2
Affiliations

The role of biomarkers in diagnosis of COVID-19 - A systematic review

Muhammed Kermali et al. Life Sci. .

Abstract

Aims: As of the 28th April 2020, the COVID-19 pandemic has infiltrated over 200 countries and affected over three million confirmed people. We review different biomarkers to evaluate if they are able to predict clinical outcomes and correlate with the severity of COVID-19 disease.

Methods: A systematic review of the literature was carried out to identify relevant articles using six different databases. Keywords to refine the search included 'COVID-19', 'SARS-CoV2', 'Biomarkers', among others. Only studies which reported data on pre-defined outcomes were included.

Key findings: Thirty-four relevant articles were identified which reviewed the following biomarkers: C-reactive protein, serum amyloid A, interleukin-6, lactate dehydrogenase, neutrophil-to-lymphocyte ratio, D-dimer, cardiac troponin, renal biomarkers, lymphocytes and platelet count. Of these, all but two, showed significantly higher levels in patients with severe complications of COVID-19 infection compared to their non-severe counterparts. Lymphocytes and platelet count showed significantly lower levels in severe patients compared to non-severe patients.

Significance: Although research is still in its early stages, the discovery of how different biomarkers behave during the course of the disease could help clinicians in identifying severe disease earlier and subsequently improve prognosis. Nevertheless, we urge for more research across the globe to corroborate these findings.

Keywords: Biomarkers; Blood tests; COVID-19; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that there are no conflicts of interest.

Figures

Fig. 1
Fig. 1
PRISMA flow diagram.
See this image and copyright information in PMC

References

    1. Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., et al. 2020 Feb 11. Severe Acute Respiratory Syndrome-related Coronavirus: The Species and Its Viruses – A Statement of the Coronavirus Study Group. bioRxiv. 2020.02.07.937862.
    1. Chan J.W.M., Ng C.K., Chan Y.H., Mok T.Y.W., Lee S., Chu S.Y.Y., et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS) Thorax. 2003 Aug;58(8):686–689. - PMC - PubMed
    1. Booth T.F., Kournikakis B., Bastien N., Ho J., Kobasa D., Stadnyk L., et al. Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units. J. Infect. Dis. 2005 May 1;191(9):1472–1477. - PMC - PubMed
    1. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 [cited 2020 Apr 28]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK554776/. - PubMed
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. Feb 15. - PMC - PubMed

Publication types

MeSH terms